These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 12704672)

  • 21. Serological mapping of the TAG-72 tumor-associated antigen using 19 distinct monoclonal antibodies.
    Kuroki M; Fernsten PD; Wunderlich D; Colcher D; Simpson JF; Poole DJ; Schlom J
    Cancer Res; 1990 Aug; 50(16):4872-9. PubMed ID: 1696162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Purification and characterization of corresponding antigen recognized by monoclonal antibody 183B2 against ovarian carcinoma].
    Guo HF; Feng J; Zhang H; Yao Y; Cheng HY
    Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):614-8. PubMed ID: 16202318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the 52 kDa antigen of Salmonella typhi: physicochemical stability, purification by affinity chromatography and immunochemical specificity.
    Anuntagool N; Sarasombath S; Ratanabanangkoon K
    Southeast Asian J Trop Med Public Health; 1991 Sep; 22(3):362-71. PubMed ID: 1726337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the purification of thrombopoietin from kidney cell culture medium.
    McDonald TP; Cottrell M; Clift R; Khouri JA; Long MD
    J Lab Clin Med; 1985 Aug; 106(2):162-74. PubMed ID: 4020244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.
    Edwards DP; Grzyb KT; Dressler LG; Mansel RE; Zava DT; Sledge GW; McGuire WL
    Cancer Res; 1986 Mar; 46(3):1306-17. PubMed ID: 3510721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistological and immunochemical characterization of a novel pancreatic cancer-associated antigen MUSE11.
    Ban T; Imai K; Yachi A
    Cancer Res; 1989 Dec; 49(24 Pt 1):7141-6. PubMed ID: 2479476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the shed form of the human tumor-associated glycoprotein (TAG-72) from serous effusions of patients with different types of carcinomas.
    Katari RS; Fernsten PD; Schlom J
    Cancer Res; 1990 Aug; 50(16):4885-90. PubMed ID: 2379152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of a new tumor associated antigen from mammary carcinoma cells by monoclonal antibodies.
    Czuppon AB
    Biochem Int; 1987 Aug; 15(2):359-72. PubMed ID: 3435529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification and characterization of a 36 kDa antigen of Mycobacterium leprae.
    de Wit MY; Klatser PR
    J Gen Microbiol; 1988 Jun; 134(6):1541-8. PubMed ID: 3065448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of new pancreatic cancer-reactive monoclonal antibodies directed against purified mucin.
    Ho JJ; Bi N; Yan PS; Yuan M; Norton KA; Kim YS
    Cancer Res; 1991 Jan; 51(1):372-80. PubMed ID: 1703039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial purification and characterization of tumor associated antigen in cervical carcinoma.
    Das S; Chatterjee R; Chattopadhyay U; Roy Chowdhury J
    Neoplasma; 1985; 32(1):21-30. PubMed ID: 2580245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the target of monoclonal antibody A6H as dipeptidyl peptidase IV/CD26 by LC MS\MS.
    Hass GM; Meyer JL; Newitt RA; Labuda T; Brown L; Aebersold R; Vessella RL
    Hybridoma; 2001 Aug; 20(4):231-6. PubMed ID: 11604108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of a squamous cell lung carcinoma-associated antigen, KA-32, in human tissues and sera defined by monoclonal antibody KM-32.
    Hanai N; Shitara K; Yoshida H
    Cancer Res; 1986 Oct; 46(10):5206-10. PubMed ID: 3530436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal antibody 5C3 raised against formalin fixed paraffin-embedded invasive breast tumour tissue: characterisation of its reactive antigen via immunoprecipitation and internal sequencing.
    Larkin A; Moran E; Kennedy SM; Clynes M
    J Immunol Methods; 2005 Aug; 303(1-2):53-65. PubMed ID: 16038928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue.
    Molinolo A; Simpson JF; Thor A; Schlom J
    Cancer Res; 1990 Feb; 50(4):1291-8. PubMed ID: 2297774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification and characterization of an osteoclast membrane glycoprotein with homology to manganese superoxide dismutase.
    Oursler MJ; Li L; Osdoby P
    J Cell Biochem; 1991 Jul; 46(3):219-33. PubMed ID: 1723067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification and characterization of a high molecular weight glycoprotein detectable in human milk and breast carcinomas.
    Sekine H; Ohno T; Kufe DW
    J Immunol; 1985 Nov; 135(5):3610-5. PubMed ID: 4045199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3.
    Johnson VG; Schlom J; Paterson AJ; Bennett J; Magnani JL; Colcher D
    Cancer Res; 1986 Feb; 46(2):850-7. PubMed ID: 3940648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partial purification of organ-specific neoantigens from human colon and breast cancer by affinity chromatography with human tumour-specific gamma-globulin.
    Thomson DM; Tataryn DN; Schwartz R
    Br J Cancer; 1980 Jan; 41(1):86-99. PubMed ID: 7362781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification of three major forms of beta-hCG from urine and production of polyclonal antibodies against them.
    Khademi F; Hamzehee K; Mostafaie A; Hajihossaini R
    Clin Biochem; 2009 Sep; 42(13-14):1476-82. PubMed ID: 19501580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.